Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0116 | 0.0109 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0228 | 0.3501 | 0.3497 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0033 | 0.0263 | 0.0256 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0116 | 0.0489 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0263 | 0.0513 |
Brugia malayi | hypothetical protein | 0.0039 | 0.0374 | 0.0367 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0017 | 0.0007 | 0.0001 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0305 | 0.4762 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0116 | 0.0109 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0263 | 0.0513 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0318 | 0.4991 | 1 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0043 | 0.0429 | 0.0887 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0374 | 0.0261 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0033 | 0.0263 | 0.0256 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0116 | 0.0424 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0016 | 0.5 |
Schistosoma mansoni | gabp alpha | 0.0079 | 0.1036 | 0.2065 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0079 | 0.1036 | 0.103 |
Brugia malayi | MH2 domain containing protein | 0.0131 | 0.1889 | 0.1884 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0116 | 0.0229 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0039 | 0.0374 | 0.0736 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0116 | 0.0229 |
Loa Loa (eye worm) | fli-1 protein | 0.0241 | 0.3715 | 0.371 |
Brugia malayi | Ets-domain containing protein | 0.0079 | 0.1036 | 0.103 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0116 | 0.0424 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0374 | 0.0261 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0374 | 0.0261 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0131 | 0.1889 | 0.1884 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0116 | 0.0424 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0039 | 0.0374 | 0.0367 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0033 | 0.0263 | 0.0513 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0116 | 0.0424 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.0626 | 0.062 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0116 | 0.5 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0116 | 0.5 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0016 | 0.0068 |
Brugia malayi | Pre-SET motif family protein | 0.0228 | 0.3501 | 0.3497 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0016 | 0.0009 |
Toxoplasma gondii | hypothetical protein | 0.0049 | 0.0534 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0263 | 0.0513 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0116 | 0.0424 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.0626 | 0.062 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0116 | 0.0109 |
Mycobacterium ulcerans | hypothetical protein | 0.016 | 0.2376 | 1 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0079 | 0.1036 | 0.103 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.034 | 0.0333 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.016 | 0.2376 | 1 |
Brugia malayi | Fli-1 protein | 0.0241 | 0.3715 | 0.371 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0144 | 0.2106 | 0.4415 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.0626 | 0.062 |
Onchocerca volvulus | 0.026 | 0.4024 | 1 | |
Onchocerca volvulus | 0.0033 | 0.0263 | 0.0375 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0317 | 0.4959 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0033 | 0.0263 | 0.4853 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0305 | 0.4762 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0116 | 0.0489 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0263 | 0.0256 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0116 | 0.0229 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0626 | 0.062 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0018 | 0.0016 | 1 |
Trichomonas vaginalis | serine threonine-protein kinase, putative | 0.0317 | 0.4959 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0016 | 0.0009 |
Brugia malayi | Ets-domain containing protein | 0.0079 | 0.1036 | 0.103 |
Trypanosoma brucei | DNA polymerase beta thumb, putative | 0.0043 | 0.0429 | 0.0887 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0116 | 0.0109 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0039 | 0.0374 | 0.0367 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0374 | 0.0261 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0043 | 0.0429 | 0.0887 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0016 | 0.0009 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0305 | 0.4762 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0018 | 0.0016 | 0.034 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0043 | 0.0429 | 0.0887 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0032 | 0.0243 | 0.0236 |
Schistosoma mansoni | ets-related | 0.0241 | 0.3715 | 0.7439 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.0845 | 0.0839 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0144 | 0.2106 | 0.4415 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0116 | 0.0109 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0016 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0016 | 0.0009 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0116 | 0.0424 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0131 | 0.1889 | 0.1884 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 0.0374 | 0.0736 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.034 | 0.0333 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0116 | 0.0109 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0052 | 0.0584 | 0.1213 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0116 | 0.0424 |
Plasmodium vivax | SET domain protein, putative | 0.0033 | 0.0263 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0116 | 0.0424 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.034 | 0.0667 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0033 | 0.0263 | 0.0256 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0144 | 0.2106 | 0.4415 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0079 | 0.1036 | 0.103 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0305 | 0.4762 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0017 | 0.0007 | 0.0031 |
Brugia malayi | Pre-SET motif family protein | 0.0033 | 0.0263 | 0.0256 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.585 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.359 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.991 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.965 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.921 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.91 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.904 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.898 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.